 |
 |
- Tibotec DUET study- TMC 125+ TMC 114, see "get help page" for comments on this study
- Merck's integrase inhibitor MRK-518 phase III BENCHMRK study
- List of Experimental Agents from hivandhepatitis.com
- Acria.org Clinical
Trials
- GW873140
to Treat HIV-1 Infected Adults
This study is currently recruiting patients
- Tipranavir/Ritonavir
in HIV Patients with Limited Treatment Options
Nationwide - This study is currently recruiting patients
-
TNX-355 with Optimized Background Therapy (OBT) in Treatment-Experienced
Subjects with HIV-1
Nationwide - This study is currently recruiting patients
-
Safety and Effectiveness of the Oral HIV Entry Inhibitor SCH 417690
in HIV Infected Patients
Nationwide - This study is currently recruiting patients
-
Safety and Activity of the Oral HIV Entry Inhibitor AMD11070 in HIV
Infected Patients
Alabama - This study is not yet open for patient recruitment
- Phase 2 study of TMC114 and low dose ritonavir in HIV-1 infected subjects
Nationwide - This study is currently recruiting patients
- Safety and Efficacy of PRO 542 in the Treatment of HIV-Infected Patients
New York - This study is currently recruiting patients